MARKET

OGEN

OGEN

ORAGENICS
AMEX

Real-time Quotes | Nasdaq Last Sale

0.6370
+0.0286
+4.70%
Closed 17:42 09/17 EDT
OPEN
0.6100
PREV CLOSE
0.6084
HIGH
0.6550
LOW
0.6061
VOLUME
3.29M
TURNOVER
--
52 WEEK HIGH
3.740
52 WEEK LOW
0.3500
MARKET CAP
29.38M
P/E (TTM)
-0.8233
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of OGEN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

OGEN News

  • Who Has Been Buying Oragenics, Inc. (NYSEMKT:OGEN) Shares?
  • Simply Wall St..09/10 15:41
  • Oragenics Inc. to Present September 10 at the 21st Annual Rodman and Renshaw Global Investment Conference
  • Business Wire.09/06 22:29
  • Playing House: An Aggressive 40%+ Yielding Securities Lending Strategy
  • Seeking Alpha - Article.08/23 08:21
  • Oragenics, Inc. to Present Overview of Lantibiotics Pipeline at the Annual Military Health System Research Symposium
  • Business Wire.08/20 12:00

More

Industry

Pharmaceuticals
+0.65%
Pharmaceuticals & Medical Research
+0.57%

Hot Stocks

Name
Price
%Change

About OGEN

Oragenics, Inc. develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The Company is focused on offering antibiotics against infectious disease and on developing treatments for oral mucositis. It is engaged in developing its antibiotic product candidate, MU1140, as well as other homolog antibiotic product candidates; researching AG013 in connection with the treatment of Oral Mucositis; commercializing its ProBiora3 probiotic products, and has other product candidates for out licensing or partnering. MU1140 is an antibiotic that is produced by the parent of the SMaRT strain. ProBiora3 is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145. LPT3-04 is a compound, which is consumed in the human diet in small amounts and results in dose-dependent weight loss in experimental animal models.
More

Webull offers Oragenics Inc (OGEN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.